Coronavirus (COVID-19) updates for UC San Diego Health patients and visitors. Learn More


Moores Cancer Center Press Releases

For news coverage, see In the News.

Researchers with UC San Diego School of Medicine and Moores Cancer Center say active surveillance is safe for African American men with low-risk prostate cancer.
UC San Diego researchers use experimental artificial intelligence system called DrugCell to predict the best approach to treating cancer.
J. Silvio Gutkind, PhD, has been named chair of the Department of Pharmacology at UC San Diego School of Medicine.
Patients receiving care at Moores Cancer Center at UC San Diego Health had better outcomes if they received personalized cancer therapy.
UC San Diego School of Medicine researchers reported that genetic testing is cost-effective and beneficial for newly diagnosed patients with metastatic gastrointestinal stromal tumors (GIST), a rare t ...
Moores Cancer Center at UC San Diego Health is using advanced imaging, genomics, personalized medicine and new therapies to treat patients like Brian McCloskey, who has stage IV prostate cancer.
UC San Diego researchers describe how the functional loss of a single gene negatively impacts neural development and promotes the growth of a particularly deadly form of pediatric brain cancer.
Two UC San Diego School of Medicine-led analyses report that e-cigarettes are not effective in helping adults to quit smoking.
UC San Diego researchers discovered that tumor cells in younger and female patients accumulate cancer-causing mutations that are more poorly presented to the immune system, better enabling tumors to e ...

Media Contacts

For more information, contact our public information officers.

Social Media

Follow our doctors in the news, or learn about the latest research and treatments.

Moores Cancer Center on Facebook

 Moores Cancer Center Tumblr blog

UC San Diego Health on Facebook

UCSDHealth on Twitter

UCSDHealth on Instagram

UC San Diego Health on YouTube

UC San Diego Health Sciences
Tumblr blog